Skip to main navigation

Skip to Content

About
Overview
News & Events
- News Releases
- Events & Presentations
Financial Reports
Stock Info
Analyst Coverage
Corporate Governance
Investor Resources
- Email Alerts
- Contact Us

Events & Presentations

Events & Presentations

Presentations

Corporate Presentation, August 2024

M. Wang 2024 EHA Poster: A Multi-Center, Open-Label, Phase 1/2 Study of ONCT-808, A ROR1-Targeting CAR T Cell Therapy, in Adults with Relapsed/Refractory Aggressive B Cell Lymphomas

YU ASCO GU 2024 – TIP PHASE 1/2 STUDY OF ONCT-534 in mCRPC

Bi SITC 2023 Development of a High Yield Fully Automated ONCT-808 Autologous ROR1 CAR T Cell Clinical Manufacturing Process

Bi SITC 2023 - ONCT-808 ROR1 CAR T Cells Induce Significant Cancer Cell Death in MCL Cells

Narayanan SUO 2022 Poster Dual-Action Androgen Receptor Inhibitors (DAARI)

Upcoming Events

More events are coming soon.

Past Events

More events are coming soon.

Media Events

ZILO-301 Study at EHA 2022 Interview with Salim Yazji, courtesy of VJHemOnc

Jun 22, 2022

Click here to watch the interview

Big Biz Show Interview

Aug 24, 2021

Click here to watch the interview

© 2024 Oncternal Therapeutics, Inc. All rights reserved.